CN104812386A - 治疗的化合物 - Google Patents

治疗的化合物 Download PDF

Info

Publication number
CN104812386A
CN104812386A CN201380048085.4A CN201380048085A CN104812386A CN 104812386 A CN104812386 A CN 104812386A CN 201380048085 A CN201380048085 A CN 201380048085A CN 104812386 A CN104812386 A CN 104812386A
Authority
CN
China
Prior art keywords
alkyl
cycloalkyl
halogen
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380048085.4A
Other languages
English (en)
Chinese (zh)
Inventor
Z.金
L.陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation
Original Assignee
University of Iowa Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation filed Critical University of Iowa Research Foundation
Publication of CN104812386A publication Critical patent/CN104812386A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201380048085.4A 2012-07-25 2013-07-25 治疗的化合物 Pending CN104812386A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261675665P 2012-07-25 2012-07-25
US61/675665 2012-07-25
US201261720785P 2012-10-31 2012-10-31
US61/720785 2012-10-31
PCT/US2013/052081 WO2014018765A1 (en) 2012-07-25 2013-07-25 Therapeutic compounds

Publications (1)

Publication Number Publication Date
CN104812386A true CN104812386A (zh) 2015-07-29

Family

ID=49997838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380048085.4A Pending CN104812386A (zh) 2012-07-25 2013-07-25 治疗的化合物

Country Status (12)

Country Link
US (1) US9346781B2 (cg-RX-API-DMAC7.html)
EP (1) EP2877172A4 (cg-RX-API-DMAC7.html)
JP (1) JP6289463B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150036742A (cg-RX-API-DMAC7.html)
CN (1) CN104812386A (cg-RX-API-DMAC7.html)
AU (1) AU2013295723A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015001515A2 (cg-RX-API-DMAC7.html)
CA (1) CA2879908A1 (cg-RX-API-DMAC7.html)
IL (1) IL236873A0 (cg-RX-API-DMAC7.html)
IN (1) IN2015KN00386A (cg-RX-API-DMAC7.html)
MX (1) MX2015001134A (cg-RX-API-DMAC7.html)
WO (1) WO2014018765A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025231146A1 (en) * 2024-04-30 2025-11-06 University Of Iowa Research Foundation Synthetic superstolides and therapeutic use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANGELA ZAMPELLA等: "Studies towards the synthesis of superstolide A. Synthesis and", 《TETRAHEDRON: ASYMMETRY》 *
YAN MEI: "Syntheses of natural products OSW-1, superstolide A and their derivatives", 《THE UNIVERSITY OF LOWA, DOCTORAL THESIS》 *

Also Published As

Publication number Publication date
US9346781B2 (en) 2016-05-24
IL236873A0 (en) 2015-03-31
EP2877172A4 (en) 2016-06-15
JP2015524809A (ja) 2015-08-27
EP2877172A1 (en) 2015-06-03
US20150210664A1 (en) 2015-07-30
MX2015001134A (es) 2015-10-12
WO2014018765A1 (en) 2014-01-30
CA2879908A1 (en) 2014-01-30
AU2013295723A1 (en) 2015-02-26
JP6289463B2 (ja) 2018-03-07
KR20150036742A (ko) 2015-04-07
IN2015KN00386A (cg-RX-API-DMAC7.html) 2015-07-10
BR112015001515A2 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
JP6386171B2 (ja) 新規なアミノアルキルベンゾチアゼピン誘導体及びその用途
JP2012509351A (ja) 有機化合物のフッ素化
AU2023204584B2 (en) Synthesis of cantharidin
CA2971279C (en) Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
JP2022107010A (ja) ブリオスタチン化合物およびその調製方法
EP2786982A1 (en) Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
IL291254B1 (en) Cannabinoid derivatives and precursors, and their asymmetric production
JP6289463B2 (ja) 治療化合物
US10392338B2 (en) Spirofuranone compounds, derivatives thereof and processes for their preparation
EP1132383B1 (en) Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
JP2015512404A (ja) シュワインフルチン類似体
CN103562212B (zh) 膦酰基丁烯酸衍生物的制造方法
US20090137828A1 (en) Synthesis of 1A-Fluoro-25-Hydroxy-16-23E-Diene-26,27-Bishomo-20-Epi-Cholecalciferol
US20250326731A1 (en) Catalyst-controlled site-selective methylene c-h lactonization of dicarboxylic acids
JP3987944B2 (ja) 多置換シクロブタン及び多置換シクロブテン化合物の製造方法
JP2004307420A (ja) 細胞死抑制作用を有する化合物、およびその製造方法
Zhao Synthesis of Daucane-Type Sesquiterpenoids
WO2023205908A1 (en) Synthetic process for production of lipoxin b4 and analogues thereof
Delmain Studies of Cyclization Reactions for Oxa-Bridged Bicyclic Compounds Using Transition-Metal Catalysis
Yoo Total Synthesis of Spliceosome Modulator Pladienolide B and the Development of Enantioselective Iridium-Catalyzed Carbon-Carbon and Carbon-Nitrogen Bond Formations
JP2004315373A (ja) 抗腫瘍活性および血管新生阻害活性を有する化合物、ならびにその製造方法
KR20160008873A (ko) 신규의 베타-술핀아미노 말로네이트 유도체 및 이의 제조방법, 그리고 이를 이용한 시타글립틴의 제조방법
JP4041928B2 (ja) ジエン化合物およびその製造方法
JPWO2006009119A1 (ja) 多置換シクロブタン及び多置換シクロブテン化合物の製造方法
Sullivan The total synthesis and manipulations of norcembrenolides

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150729

RJ01 Rejection of invention patent application after publication